Stocks and Investing Stocks and Investing
Wed, April 29, 2020
Tue, April 28, 2020

Eliana Merle Maintained (APLS) at Buy with Increased Target to $61 on, Apr 28th, 2020


Published on 2024-10-27 04:22:30 - WOPRAI, Eliana Merle
  Print publication without navigation


Eliana Merle of Cantor Fitzgerald, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Buy with Increased Target from $54 to $61 on, Apr 28th, 2020.

Eliana has made no other calls on APLS in the last 4 months.



There are 4 other peers that have a rating on APLS. Out of the 4 peers that are also analyzing APLS, 2 agree with Eliana's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Laura Chico of "Wedbush" Upgraded from Sell to Hold and Held Target at $29 on, Wednesday, March 11th, 2020
  • Tiago Fauth of "Credit Suisse" Maintained at Hold with Decreased Target to $34 on, Monday, March 2nd, 2020


These are the ratings of the 2 analyists that currently disagree with Eliana


  • Steven Seedhouse of "Raymond James" Initiated at Strong Buy and Held Target at $86 on, Wednesday, April 1st, 2020
  • Matthew Luchini of "BMO Capital" Initiated at Buy and Held Target at $54 on, Tuesday, March 31st, 2020
Contributing Sources